Pre-market hot trades in US stocks: Powell Industries up 9.77% in pre-market; Credo Tech up 7.72% in pre-market

Pre-market Hot Trades in US Stocks

Powell Industries is up 9.77% in pre-market trading. There have been no significant news recently for Powell Industries; trading is active with clear capital flows. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation. no_news

Credo Tech is up 7.72% in pre-market trading. Based on recent key news:

1. On July 30, analyst ratings showed that although Credo Technology Group was rated as a buy, top analysts believe there are other stocks that are more attractive. This information may lead investors to reassess their portfolios, driving the stock price up.

2. On July 29, it was observed that institutional investors hold more than 60% of Credo Technology Group's shares and are actively increasing their positions. This institutional activity reflects market optimism about the company, further driving the stock price up.

3. On July 28, market optimism about the macroeconomic environment increased, especially in the tech sector, driving up several tech stocks, including Credo Technology Group. The tech industry has performed strongly recently, with noticeable capital inflows.

Top Gainers in Pre-market US Stocks

WeBus is up 264.00% in pre-market trading. Based on recent key news:

1. On July 30, Wetour Robotics announced a stock consolidation plan with a ratio of 1 for 100, expected to take effect on August 3. This move aims to enhance the market liquidity and attractiveness of the stock, driving the price up.

2. On July 29, the SEC issued a notice reminding investors not to overly rely on forward-looking statements and emphasized that the company discussed additional factors in its SEC filings. This increased market confidence in the company's future development, further driving the stock price up.

3. On July 29, Fermi and Galaxy Digital showed uncertainty in response to changes in cryptocurrency regulation, leading investors to turn to traditional commodities and physical assets as safe-haven tools. This shift in market sentiment also positively impacted WeBus's stock price. Changes in cryptocurrency regulation affect market sentiment, with traditional commodities and physical assets receiving attention.

Replimune is up 119.04% in pre-market trading. Based on recent key news:

1. On July 28, FDA reviewers expressed concerns about Replimune's RP1 drug trial, stating that the trial data was insufficient to prove its efficacy, leading to a 21% drop in the stock price in pre-market trading.

2. On July 30, at the FDA advisory committee meeting, an external expert panel voted in favor of the RP1 drug trial results, deeming them clinically significant, which drove the stock price up.

3. On July 31, Replimune announced that the results of the FDA advisory committee meeting were favorable, and it is expected that the RP1 drug will be resubmitted for approval on August 2, further boosting the stock price The FDA review results have a significant impact, increasing regulatory risks in the industry.

Mangoceuticals surged 86.27% in pre-market trading. Based on recent key news:

1. On July 30, Mangoceuticals announced a new product announcement, stating that its latest developed drug has received FDA approval. This news greatly boosted market confidence, leading to a substantial increase in stock prices.

2. On July 29, the company released its second-quarter financial report, showing that its revenue and net profit both exceeded market expectations. The strong financial performance further propelled the rise in stock prices.

3. On July 28, a well-known analyst upgraded the rating for Mangoceuticals, believing that its future growth potential is enormous. This positive rating change attracted more investor attention, driving up the stock price. The pharmaceutical industry has performed strongly recently, with significant capital inflows